跳至主要内容
临床试验/NCT00716924
NCT00716924已完成3 期

Clopidogrel 600 mg and 300 mg as a Loading Dose Prior to Percutaneous Coronary Intervention And Serum Troponin Level Elevation: A Pilot Study

Sanofi1 个研究点 分布在 1 个国家目标入组 155 人开始时间: 2004年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Sanofi
入组人数
155
试验地点
1
主要终点
Incidence of post-percutaneous coronary intervention elevation of troponin T.

研究概览

简要总结

Primary Objective: To test if 600 mg of clopidogrel loading dose administered ≥ 6 and ≤ 24 hours prior to PCI produce a greater decrease of periprocedural release of biochemical markers (CK, CK-MB, and troponin-T and/or I) of myocardial necrosis, compared to 300 mg loading dose, given ≥ 6 and ≤ 24 hours prior to PCI or 600 mg loading dose of clopidogrel, administered immediately (≤ 45 minutes) before PCI.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients having symptomatic coronary artery disease with objective evidence of ischemia (eg, symptoms of angina pectoris, positive stress test results or dynamic electrocardiographic (ECG) changes).
  • Patients undergoing stent implantation

排除标准

  • Any known contraindication to the use of aspirin or clopidogrel.
  • Patients receiving clopidogrel within 10 days, thrombolytics within 24 hours or receiving oral anticoagulation therapy
  • Elective administration of IIb/IIIa inhibitors.
  • Cardiogenic shock
  • Acute MI< 24 hours
  • BP systolic <100 mmHg
  • Left ventricular ejection fraction < 30%
  • Heart failure, NYHA class III or IV
  • Severe renal insufficiency (creatinine > 3.0 mg/dL)
  • Platelet count <100,000/mm³
  • Target lesion in a venous bypass graft
  • Target lesion in a chronic occlusion
  • The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

研究组 & 干预措施

1

Experimental

300-mg loading dose of clopidogrel given ≥ 6 and ≤ 24 hours before PCI

干预措施: Clopidogrel (Drug)

2

Experimental

600-mg loading dose of clopidogrel given ≥ 6 hours and ≤ 24 before PCI.

干预措施: Clopidogrel (Drug)

3

Experimental

600-mg loading dose of clopidogrel given immediately (≤ 45 minutes) before PCI.

干预措施: Clopidogrel (Drug)

结局指标

主要结局

Incidence of post-percutaneous coronary intervention elevation of troponin T.

时间窗: At 6 and 12 months post-PCI

次要结局

  • Adverse events.(From the beginning to the end of the study)
  • Standard hematology and blood chemistry.(At 6 and 12 months post-PCI)

研究者

发起方
Sanofi
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

CASTLE (Clopidogrel And Serum Troponin Level... | 临床试验